-+ 0.00%
-+ 0.00%
-+ 0.00%

Cardiff Oncology Reports Positive Phase 2 Results for Onvansertib in First-Line RAS-Mutated mCRC

Reuters·01/27/2026 17:11:09

Please log in to view news